India’s first Clinically tested supplemental treatment for COVID-19 AAYOG Advance

 

This ‘Make in India’ syrup has successfully helped in treating over 75000 COVID-19 patients and prescribed by hundreds of doctors

Ahmedabad : With the second wave of COVID-19 pandemic wreaking havoc across the world, a breakthrough has been achieved to provide effective medical care and supplemental treatment for COVID-19 patients.

‘AAYOG Advance’, a plant-based liquid formulation has been found to be highly effective and safe in not only one but two detailed human clinical trials conducted at two leading government Hospitals in Ahmedabad.

AAYOG is a commercial brand of Aayudh.

As per the report of the second clinical trial of Sola Civil Hospital, Ahmedabad – After just four days of supplemental treatment with ‘AAYOG Advance’, it effectively reduced the viral load in the patients, without any reported side effects. Not only this, all the COVID-19 patients that were treated with ‘AAYOG Advance’ witnessed significant improvements in symptoms like body temperature, cough, shortness of breath etc.

Peer reviewed by Harvard Medical School – The journal ‘Contemporary Clinical Trials Communication’, published by the world’s leading publisher of science and health information: Elsevier, recently made public that the supplemental treatment of AAYOG Advance was safe and effective in mild symptomatic COVID-19 patients. The research is also published in National Center for Biotechnology Information – National Institute of Health, Government of USA’s website at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948525/.

The first human clinical trial and study was conducted in June 2020, at Smt. NHL Municipal Medical College and SVPIMSR, Ellisbridge, Ahmedabad. The second human clinical trial was performed in January 2021, at GMERS Medical College and Hospital, Sola, Ahmedabad. The first study examined its effect on mild symptomatic COVID-19 patients. The successful results of the first clinical study led to the subsequent study of a larger trial – moderately symptomatic COVID-19 patients with morbidities and co-morbidities. Co-morbid patients have a higher probability of developing complications of the COVID-19 disease. These patients were administered 15mL of ‘AAYOG Advance’ (along with Standard of Care) 4 times a day and they recovered without getting into the complications.

‘AAYOG Advance’ is a liquid formulation comprising 21 different types of plant-based extracts. Ayurvedic scriptures report these ingredients to be effective and safe to be used for human consumption. These medicinal ingredients are processed using Quantum technology and Colloidal Sciences and are broken down to angstrom-sized (i.e. one-tenth of a nanometre) particles. This makes them far more effective.

Speaking about the product, Mr. Harpal Vala, Director, Kepler Healthcare Pvt Ltd, said, “We all are witnessing the era of the pandemic which is perhaps once in the lifetime for all of us. When many treatment options are available in the world but with no sure shot results; I think the addition of AAYOG Advance can be a great relief to the world if consumed in time. AAYOG Advance is recommended by hundreds of doctors and has been used to treat over 75,000 patients.”The product has been approved by State FDCA (Ayurveda), Gujarat, and licensed for manufacturing and marketing purposes.
Currently, two products fall under the umbrella of ‘AAYOG’: ‘AAYOG Advance’ and ‘AAYOG Protect’. As described, ‘ AAYOG Advance’ is a safe and effective concomitant treatment for those who are diagnosed with COVID-19. However, the families of these patients must take extra care to safeguard them from contacting the virus; ‘AAYOG Protect’ plays a pivotal role here.‘AAYOG Protect’ is a prophylactic health supplement that helps the body fight against threats or pathogens and helps dispose of them when found. ‘AAYOG Protect’ works by enhancing the body’s immune system and improving its ability to detect pathogens. So far over1,90,000 quarantined family members have been kept safe through AAYOG Protect. This way, when a pathogen enters our body and tries to infect it, our body’s immune system is already vigilant and disposes of the pathogen before it gets a chance to spread in our body and make us sick.
What the expert say:
“‘AAYOG Advance’ was found to be safe without any side effects, adverse effects, or drug-to-drug reactions, when given concomitantly with Standard of Care (SOC) Treatment in moderate symptomatic COVID-19 patients with comorbidities (pre-existing health conditions). The reduction in viral load (inferred by the increase in CT value), in the case of AAYOG Advance treatment, was found statistically significant (p<0.0001) within the group as compared to within the group comparison of Standard of Care Treatment alone (p<0.01) after 4 days of the treatment.”
– Dr. Parul Bhatt, Principal Investigator, GMERS Medical College and Hospital, Ahmedabad

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

ICICI Lombard announces appointment of Priya Deshmukh as Head – Health Products, Operations & Services

  ICICI Lombard announces appointment of Priya Deshmukh as Head – Health Products, Operations & Services Mumbai – Health insurance is the fastest growing industry segment and it has been a key area of focus for ICICI Lombard General Insurance Limited. Over the past few quarters, ICICI Lombard has invested significantly in growing its distribution […]

Paytm – पेटीएम क्यूआर, साउंडबॉक्स और कार्ड मशीन 15 मार्च के बाद भी करते रहेंगे काम

  पेटीएम क्यूआर, साउंडबॉक्स और कार्ड मशीन 15 मार्च के बाद भी करते रहेंगे काम नई दिल्ली  :  भारत की दिग्गज पेमेंट और फाइनेंशियल सर्विस कंपनी पेटीएम ने घोषणा की है कि उसके मेड-इन-इंडिया क्यूआर कोड, साउंडबॉक्स और कार्ड मशीन 15 मार्च, 2024 के बाद भी सामान्य रूप से काम करते रहेंगे। यह आश्वासन भारतीय […]